Adding the Center for Drug Evaluation and Research (CDER) to PAR-14-237

Notice Number: NOT-FD-15-002

Key Dates
Release Date: February 26, 2015

Related Announcements
PAR-14-237

Issued by
U.S. Food and Drug Administration (FDA)

Purpose

The purpose of this notice is to add the Center for Drug Evaluation and Research (CDER) to PAR-14-237 as a participating organizations. And to also add "Late applications will not be accepted" to the Application Due Date section, and to Part 2.  Full Text of Announcement Section I. Funding Opportunity Description after the advance permission to submit an application section.

Inquiries

Please direct all inquiries to:


Martin Bernard
Food and Drug Administration (FDA)
Division of Acquisition Support and Grants
Office of Acquisition and Grants Services (HFA-500)
Email: Martin.Bernard@fda.hhs.gov